SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-23-093909
Filing Date
2023-12-07
Accepted
2023-12-07 09:08:12
Documents
4
Period of Report
2023-12-28

Document Format Files

Seq Description Document Type Size
1 PROXY STATEMENT def14a1223_virpaxpharma.htm DEF 14A 874345
2 GRAPHIC tvirpax_logo.jpg GRAPHIC 89395
3 GRAPHIC tproxy_001.jpg GRAPHIC 1143078
4 GRAPHIC tproxy_002.jpg GRAPHIC 1419708
  Complete submission text file 0001213900-23-093909.txt   4528966
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-4597
Virpax Pharmaceuticals, Inc. (Filer) CIK: 0001708331 (see all company filings)

IRS No.: 821510982 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40064 | Film No.: 231471194
SIC: 2834 Pharmaceutical Preparations